In addition, SOCs are often discussed as potential novel targets for these neurological diseases (Wu et al., 2011; Gao et al., 2013; Cui et al., 2017; Stegner et al., 2019; Waldron et al., 2019). The gene discussed is CISH; the disease is nervous system disorder.